Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Oncology Letters|March 20, 2015
Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagiaMami Yamashita, Hideomi Yamashita, Shino Shibata, et al.
World Journal of Gastrointestinal Oncology|February 26, 2014
Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancerHideomi Yamashita, Kae Okuma, Akihiro Nomoto, et al.
Practical Radiation Oncology|January 13, 2021
Helical Skin Radiation Therapy Including Total Skin Radiation Therapy Using Tomotherapy for Primary Cutaneous Lymphoma With Bone Marrow Suppression as a Related Adverse EventMayuka Kitaguchi, Hideomi Yamashita, Ryosuke Takenaka, et al.
Japanese Journal of Clinical Oncology|November 14, 2013
Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancerHideomi Yamashita, Mami Omori, Kae Okuma, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2008
Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancerHideomi Yamashita, Naoya Murakami, Takao Asari, et al.
The Journal of Obstetrics and Gynaecology Research|July 30, 2010
Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancerKae Okuma, Hideomi Yamashita, Kei Kawana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2010
Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysisHideomi Yamashita, Kae Okuma, Reiko Wakui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II studyHideomi Yamashita, Mami Omori, Ryousuke Takenaka, et al.
Japanese Journal of Clinical Oncology|February 4, 2012
Correlation between bladder volume and irradiated dose of small bowel in CT-based planning of intracavitary brachytherapy for cervical cancerHideomi Yamashita, Keiichi Nakagawa, Kae Okuma, et al.
Radiation Oncology (London, England)|January 20, 2016
Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancerHideomi Yamashita, Akihiro Haga, Ryousuke Takenaka, et al.
Pageof 11